Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
A Study of JNJ-88998377 for Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT06470438. IPD Sharing: YES. Countries: 7. Publications: 0.
B Cell Lymphocyte in Humoral Rejection and Alloimmunisation
ClinicalTrials.gov study NCT03016455. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT02449278. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Analysis of T and B Cell Repertoire Changes in Response to Orencia® (Abatacept) in Rheumatoid Arthritis
ClinicalTrials.gov study NCT05782335. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma
ClinicalTrials.gov study NCT06929624. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
T and B Cell Response to Avian Flu Vaccine
ClinicalTrials.gov study NCT00337896. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intravenous Immunoglobulin Replacement Therapy for Persistent COVID-19 in Patients With B-cell Impairment
ClinicalTrials.gov study NCT06159283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tafasitamab and Lenalidomide as First Salvage Therapy for Residual Large B Cell Lym
ClinicalTrials.gov study NCT06760156. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Selinexor Plus R-CHOP in High-risk GCB-subtype Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05422066. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety and Efficiency Study of CD19-PD1-CART Cell in Relapsed/Refractory B Cell Lymphoma
ClinicalTrials.gov study NCT04163302. IPD Sharing: NO. Countries: 1. Publications: 0.
IASO208 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
ClinicalTrials.gov study NCT07309900. IPD Sharing: NO. Countries: 1. Publications: 0.
Epcoritamab Compared to Observation for Treating B-cell Lymphoma Patients Not in Complete Remission After CD19-directed CAR-T Therapy
ClinicalTrials.gov study NCT06238648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)
ClinicalTrials.gov study NCT04665115. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Genetically Modified T-cells (CMV-Specific CD19-CAR T-cells) Plus a Vaccine (CMV-MVA Triplex) Following Stem Cell Transplantation for the Treatment of Intermediate or High Grade B-cell Non-Hodgkin Lym
ClinicalTrials.gov study NCT05432635. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of GC022F CAR-T Cell Immunotherapy for Relapsed or Refractory B- NHL
ClinicalTrials.gov study NCT04412174. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT04432207. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Decitabine-primed Tandem CD19/CD20 CAR T Cells Treatment in r/r B-NHL
ClinicalTrials.gov study NCT04697940. IPD Sharing: NO. Countries: 1. Publications: 0.
To Evaluate the Safety and Tolerability of Human CD19-CD22 Targeted T Cells Injection for Subjects With R/R B-ALL.
ClinicalTrials.gov study NCT05223686. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of ATG-031 in Advanced Solid Tumors or B-cell Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT06028373. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
ClinicalTrials.gov study NCT00829205. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.